ArticleArthroplasty today2026
Characteristics and Risk Factors of Atypical Periprosthetic Femoral Fractures Following Total Hip Arthroplasty: A Systematic Review and Meta-Analysis.
Article in Arthroplasty today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Atypical periprosthetic femoral fractures (APFFs) are a challenging, albeit uncommon, complication after total hip arthroplasty (THA). This systematic review will evaluate the characteristics and risk factors associated with APFFs following THA. Methods: A systematic search of EMBASE, MEDLINE, CENTRAL, and CINAHL was performed from inception to October 6, 2025, for studies reporting APFFs after THA. Patient, surgical, and radiographic data were extracted. Random-effects meta-analyses pooled proportions and odds ratios (ORs). Results: Eight studies comprising 1072 THA patients with periprosthetic fractures were included. APFFs accounted for 120/1072 fractures (11.2%), with a pooled proportion of 11% (95% confidence interval [CI], 7%-18%; I Conclusions: Long-term bisphosphonate use may increase APFF risk after THA. These fractures typically occur late and have characteristic clinical and radiographic features. APFFs represent a high-risk subtype of periprosthetic fracture that requires careful surveillance and thoughtful surgical management. As THA volumes rise, prospective studies and standardized diagnostic criteria are needed to clarify incidence and inform prevention. Level of Evidence: Level III, Systematic review.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.